Cargando…
Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies
The incidence of metastatic melanoma has been increasing dramatically over the last decades. Yet, there have been many new innovative therapies, such as targeted therapies and checkpoint inhibitors, which have made progress in survival for these patients. The oncology pharmacist is part of the healt...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Future Medicine Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240885/ https://www.ncbi.nlm.nih.gov/pubmed/30459938 http://dx.doi.org/10.2217/mmt-2017-0026 |
_version_ | 1783371705433980928 |
---|---|
author | Gazzé, Gabriel |
author_facet | Gazzé, Gabriel |
author_sort | Gazzé, Gabriel |
collection | PubMed |
description | The incidence of metastatic melanoma has been increasing dramatically over the last decades. Yet, there have been many new innovative therapies, such as targeted therapies and checkpoint inhibitors, which have made progress in survival for these patients. The oncology pharmacist is part of the healthcare team and can help in optimizing these newer therapies. There will be discussion about combination therapies, the oncology pharmacist's role, and issues at the core of his interest, such as drug interactions and complementary and alternative therapies. |
format | Online Article Text |
id | pubmed-6240885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Future Medicine Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-62408852018-11-20 Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies Gazzé, Gabriel Melanoma Manag Perspective The incidence of metastatic melanoma has been increasing dramatically over the last decades. Yet, there have been many new innovative therapies, such as targeted therapies and checkpoint inhibitors, which have made progress in survival for these patients. The oncology pharmacist is part of the healthcare team and can help in optimizing these newer therapies. There will be discussion about combination therapies, the oncology pharmacist's role, and issues at the core of his interest, such as drug interactions and complementary and alternative therapies. Future Medicine Ltd 2018-06-19 /pmc/articles/PMC6240885/ /pubmed/30459938 http://dx.doi.org/10.2217/mmt-2017-0026 Text en © 2018 Gabriel Gazzé This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Perspective Gazzé, Gabriel Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title | Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title_full | Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title_fullStr | Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title_full_unstemmed | Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title_short | Combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
title_sort | combination therapy for metastatic melanoma: a pharmacist's role, drug interactions & complementary alternative therapies |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240885/ https://www.ncbi.nlm.nih.gov/pubmed/30459938 http://dx.doi.org/10.2217/mmt-2017-0026 |
work_keys_str_mv | AT gazzegabriel combinationtherapyformetastaticmelanomaapharmacistsroledruginteractionscomplementaryalternativetherapies |